Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience
Background Despite growing use of the subcutaneous implantable cardioverter‐defibrillator (S‐ICD), its clinical role in arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) patients remains undefined. We aim to elucidate the cardiac phenotype, implant characteristics, and long‐term eff...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
Wiley
2018-11-01
|
| 丛编: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| 主题: | |
| 在线阅读: | https://www.ahajournals.org/doi/10.1161/JAHA.118.008782 |